Navigation Links
New Test Developed to Identify LQTS syndrome

Researchers at the Mayo Clinic have discovered the epinephrine QT stress test that can predict the long QT syndrome with an accuracy of about 75%. //

The Long QT syndrome is a rare yet almost fatal, heart rhythm disorder occurring right from birth and affecting about one in every 3000 people in the United States. Its name comes from the elongated Qt interval seen in the electrocardiogram (ECG ) of such people with the disease.

If untreated, 50% of the people with symptoms of LQTS will die within 10 years of the first diagnosis of the disease.

However type 1 LQTS, a common subtype of the LQTS syndrome may go unrecognized because the patient’s resting ECG could be normal. In the epinephrine QT stress test, a patient is medicated to stimulate the heart in such a way that it mimics exercise revealing concealed type 1 long QT syndrome with an accuracy of about 75%.

This in turn can be confirmed by a blood test for LQTS genetic testing.

147 individuals, ages 8-59, who been referred to Mayo Clinic’s Long QT Syndrome Clinic during the period between 1999 and 2002 had an epinephrine QT stress test. A paradoxical lengthening of the QT interval was observed in 96%of these patients during infusion of the epinephrine.

These results could help physicians to recognize, evaluate and diagnose LQTS.

Although the treatment for LQTS patients can vary the options include medication or the implantation of a cardioverter defibrillator.


'"/>




Page: 1

Related medicine news :

1. Scientists Developed Map For Brain Molecular Communities
2. Scientists Developed Cheap Way To Assess Sleep
3. Diabetic Friendly Egg Developed In India
4. Three In One Ultrasound Probe For 3-D Imaging Of Heart And Tissue Destruction Developed
5. Cervical Cancer Vaccine To Be Developed In India
6. Anti-Microbial Coating For Use Over Biomedical Devices Developed
7. Cure for Osteoarthritis To Be Developed
8. Mice With Human Thought Processes Could Be Developed In The Future
9. Viagra Pill For Women To Be Developed
10. Male Contraceptive Pill Being Developed By Berlin Pharmaceutical
11. New Fertility Predictor Test Developed
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: